OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB. AN OBSERVATIONAL COHORT STUDY

Kathrine Lederballe Grøn, Bente Glintborg, F. Mehnert, Mikkel Østergaard, L. Dreyer, M. Nørgaard, N. S. Krogh, Merete Lund Hetland

Original languageEnglish
Article numberTHU0667
JournalAnnals of the Rheumatic Diseases
Volume78
Issue numberSuppl. 2
Pages (from-to)630
Number of pages1
ISSN0003-4967
Publication statusPublished - 2019

Cite this